[go: up one dir, main page]

MA51018A - Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide - Google Patents

Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Info

Publication number
MA51018A
MA51018A MA051018A MA51018A MA51018A MA 51018 A MA51018 A MA 51018A MA 051018 A MA051018 A MA 051018A MA 51018 A MA51018 A MA 51018A MA 51018 A MA51018 A MA 51018A
Authority
MA
Morocco
Prior art keywords
polyaminoacid
compositions
aqueous solution
injectable aqueous
human glucagon
Prior art date
Application number
MA051018A
Other languages
English (en)
Inventor
You-Ping Chan
Richard Charvet
Alexandre Geissler
Nicolas Laurent
Romain Noel
Original Assignee
Adocia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1761809A external-priority patent/FR3074683B1/fr
Application filed by Adocia filed Critical Adocia
Publication of MA51018A publication Critical patent/MA51018A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/04—Polyamides derived from alpha-amino carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
MA051018A 2017-12-07 2018-12-07 Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide MA51018A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762606137P 2017-12-07 2017-12-07
FR1761809A FR3074683B1 (fr) 2017-12-07 2017-12-07 Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR1855939 2018-06-29

Publications (1)

Publication Number Publication Date
MA51018A true MA51018A (fr) 2020-10-14

Family

ID=66750442

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051018A MA51018A (fr) 2017-12-07 2018-12-07 Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Country Status (9)

Country Link
US (1) US20210386830A1 (fr)
KR (1) KR20240171195A (fr)
AU (1) AU2025201936A1 (fr)
IL (1) IL275184A (fr)
MA (1) MA51018A (fr)
MX (1) MX2020005915A (fr)
PH (1) PH12020550828A1 (fr)
SA (1) SA520412140B1 (fr)
WO (1) WO2019110837A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127476A1 (fr) 2018-12-19 2020-06-25 Krka, D.D., Novo Mesto Composition pharmaceutique comprenant un analogue de glp -1
WO2021123228A1 (fr) 2019-12-18 2021-06-24 Krka, D.D., Novo Mesto Composition pharmaceutique comprenant un analogue de glp-1
EP4091625A1 (fr) 2021-05-22 2022-11-23 Adocia Compositions comprenant des hormones à brève durée d'action pour traiter ou prévenir l'obésité et pompes comprenant ladite composition
WO2022248419A2 (fr) 2021-05-22 2022-12-01 Adocia Compositions comprenant des hormones à action courte pour le traitement ou la prévention de l'obésité et pompes comprenant ladite composition
EP4144362A1 (fr) 2021-09-06 2023-03-08 Adocia Compositions comprenant des hormones à brève durée d'action pour traiter ou prévenir l'obésité et pompes comprenant ladite composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202607A (en) 1968-01-10 1970-08-19 Novo Terapeutisk Labor As Improvements in or relating to stable glucagon solutions and their preparation
DE69918070T2 (de) 1998-03-13 2005-08-25 Novo Nordisk A/S Stabilisierte, wässrige Glukagonlösungen, enthaltend Detergenzien
FR2801226B1 (fr) 1999-11-23 2002-01-25 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
US20110097386A1 (en) 2009-10-22 2011-04-28 Biodel, Inc. Stabilized glucagon solutions
WO2011138802A1 (fr) 2010-05-07 2011-11-10 Sun Pharma Advanced Research Company Ltd., Solution injectable
ES2533601T3 (es) 2010-11-03 2015-04-13 Arecor Limited Nueva composición que comprende glucagón
CN104159570A (zh) 2011-12-29 2014-11-19 陈献 稳定的胰高血糖素纳米乳液
WO2013104861A1 (fr) * 2012-01-09 2013-07-18 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide substitue
WO2014096440A2 (fr) 2012-12-21 2014-06-26 Novozymes Biopharma Dk A/S Composition
EP3082817A4 (fr) 2013-12-18 2017-06-21 Aegis Therapeutics, LLC Compositions pour administration de médicaments
US9334316B2 (en) 2014-04-11 2016-05-10 Oregon Health & Science University Formulations comprising glucagon
MX2018015070A (es) * 2016-06-07 2019-05-09 Adocia Composiciones en forma de solucion acuosa inyectable, que comprende glucagon humano y un co-poliaminoacido injertado en el extremo.

Also Published As

Publication number Publication date
MX2020005915A (es) 2020-10-19
AU2025201936A1 (en) 2025-04-03
WO2019110837A1 (fr) 2019-06-13
US20210386830A1 (en) 2021-12-16
KR20240171195A (ko) 2024-12-06
IL275184A (en) 2020-07-30
PH12020550828A1 (en) 2021-05-10
SA520412140B1 (ar) 2023-02-26

Similar Documents

Publication Publication Date Title
FR3052071B1 (fr) Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
MA51018A (fr) Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
EP3298087A4 (fr) Composition d'encre sous forme de mousse et structure poreuse hiérarchique imprimée en 3d
EP3440627A4 (fr) Débrumage et restauration d'images
EP3356517A4 (fr) Constructions organoïdes cardiaques en train de battre spontanément et appareil à corps intégré sur puce contenant ceux-ci
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
MA51017A (fr) Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
MA49678A (fr) Compositions sous forme d'une solution aqueuse injectable comprenant au moins l'insuline humaine a21g et un suppresseur de glucagon a action prandiale
PL3381451T3 (pl) Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej
IL280827A (en) Integrin alpha 4 antagonists and compositions comprising same for use in treating ocular conditions
EP3474869A4 (fr) Compositions dérivées de tissu humain et leurs utilisations
EP3318580A4 (fr) Composition d'émulsion aqueuse
EP3409292A4 (fr) Composition aqueuse stabilisée comprenant du sulfate de chondroïtine et d'acide hyaluronique
EP3643729A4 (fr) Émulsion aqueuse et adhésif l'utilisant
IT201700085412A1 (it) Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
EP3369789A4 (fr) Composition d'émulsion d'encre et encre aqueuse
FR3002454B1 (fr) Composition immunogene sous forme d'emulsion
EP3342784A4 (fr) Anticorps entièrement humain inhibant en particulier la connexine 26
EP2863741A4 (fr) Composition pesticide se présentant sous la forme d'une émulsion aqueuse
EP3395893A4 (fr) Émulsion aqueuse et adhésif l'utilisant
EP3582817C0 (fr) Échafaudage tissulaire et composition d'échafaudage
MA53099A (fr) Formes d'ivosidénib et compositions pharmaceutiques
EP3677151A4 (fr) Chaise de repas pour enfants
ITUB20153104A1 (it) Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti
EP3682886A4 (fr) Composition pharmaceutique pour le traitement de l'anévrisme aortique